Posted in | News | Nanofluidics | Nanobusiness

Fluidigm Introduces New Integrated Fluidic Circuit

Today Fluidigm introduced a new integrated fluidic circuit (IFC) - called the Access Array -- specifically designed to support high-throughput re-sequencing, targeted enrichment, sample barcoding, and library preparation for sequencing using amplicon tagging. The Access Array IFC complements Fluidigm's SlingShot™ Sample Quantitation Kit that together provide researchers with a complete front-end Next-Gen Library preparation solution.

Fluidigm’s new Access Array is the first IFC that features the ability to harvest the sample out of the chip. Once the sample processing has been completed in the chip it automatically returns the sample to the inlets where they can be easily extracted and placed into a quantitation step and readied for sequencing.

Fluidigm also announced an Early Access Program for Access Arrays where researchers can submit a proposal describing how the new chip would help their next-generation library sample preparation efforts. Winners will have Fluidigm “do the work for them” - FREE*.

“Next-gen sequencing is one of the “hottest” areas in life sciences, but it is plagued with cumbersome sample preparation procedures, long cycles and costly experiments. The Access Array is our fourth integrated fluidic circuit product line. It continues to build our portfolio of enabling solutions to simplify front-end preparation and expand the applications space of next-gen sequencers,” said Gajus Worthington, Fluidigm president and chief executive officer.

The Access Array System, which consists of IFCs, instruments and software, is the first IFC product that allows next-generation sequencing users to automatically prepare their libraries and tag them with unique barcodes to allow multiplex sequencing.

In addition, targeted re-sequencing (using target enrichment) has become important as researchers look at specific regions in large cohort studies. Up-to-now, large sample studies have been too expensive and labor-intensive to be performed on next generation sequencers effectively and efficiently. Fluidigm’s Access Array System allows researchers to target specific areas of interest to be enriched and barcoded so that a large number of samples can be sequenced at the same time.

Fluidigm’s new Access Array IFC can process 48 samples against 48 amplicons (primer pairs) providing 2,304 independent reactions at a time. Only six steps are required to get the results from these thousands of experiments. Because of the Access Array chip’s ultra-tiny microfluidic reaction chambers the chip minimizes reagent consumption and costs. Operator time is reduced six-fold when compared with conventional methods.

Fluidigm’s Access Array System joins the company’s IFC portfolio of Dynamic Arrays (that maximize gene-expression analysis and genotyping efficiency), Digital Arrays (that provide a practical solution for PCR applications demanding extreme accuracy of copy number), and TOPAZ chips (that support the broadest protein crystallization exploration in the marketplace).

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fluidigm Corporation. (2019, March 19). Fluidigm Introduces New Integrated Fluidic Circuit. AZoNano. Retrieved on March 05, 2024 from https://www.azonano.com/news.aspx?newsID=12059.

  • MLA

    Fluidigm Corporation. "Fluidigm Introduces New Integrated Fluidic Circuit". AZoNano. 05 March 2024. <https://www.azonano.com/news.aspx?newsID=12059>.

  • Chicago

    Fluidigm Corporation. "Fluidigm Introduces New Integrated Fluidic Circuit". AZoNano. https://www.azonano.com/news.aspx?newsID=12059. (accessed March 05, 2024).

  • Harvard

    Fluidigm Corporation. 2019. Fluidigm Introduces New Integrated Fluidic Circuit. AZoNano, viewed 05 March 2024, https://www.azonano.com/news.aspx?newsID=12059.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.